Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mirle, Kellett"'
Autor:
Victor, Novack, Donald, Cutlip, Neal, Kleiman, Michael, Pencina, Laura, Mauri, Chen-Hsing, Yen, Peter, Berger, Steven, Goldberg, Mirle, Kellett, Ronald, Waksman, Mun, Hong, Albert E, Raizner, David J, Cohen
Publikováno v:
JACC. Cardiovascular interventions. 2(8)
The aim of this study was to compare outcomes among unselected patients undergoing percutaneous coronary intervention (PCI) with either sirolimus-eluting (SES) or paclitaxel-eluting stents (PES).Although the benefits of both SES and PES are well-esta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63c8042d08e817a881f06dc5e75cc5b4
https://pubmed.ncbi.nlm.nih.gov/19695547
https://pubmed.ncbi.nlm.nih.gov/19695547
Autor:
David J. Malenka, David Goldberg, Matthew Watkins, Patrick Magnus, Mirle Kellett, Harold Dauerman, John F. Robb, William J Phillips, Richard A Boss, John E. Jayne, Alan Wiseman, David Zlotnick, Chad M. Bohn, T.P. Ryan
Publikováno v:
Journal of the American College of Cardiology. 61:E1558
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567c2d438a98786f39f9ce6291fda7d9
https://doi.org/10.1016/s0735-1097(13)61558-2
https://doi.org/10.1016/s0735-1097(13)61558-2
Autor:
William A. Bradley, Hebe B. Quinton, Mirle Kellett, Peter VerLee, David Wennberg, David J. Malenka, Gerald T. O'Connor, John F. Robb, Michael J. Hearne, Samuel Shubrooks
Publikováno v:
Journal of the American College of Cardiology. (2):270A
We report on 521 patients≥80 years old (AGED) from a regional, populationbased study of 12,902 hospitalizations for PTCA between 10/89-12/93. Over this time period, the proportion of AGED doubled to 4.4%. Compared to younger patients, AGED were mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd827e4b358ad2fc4694eb8a4e398ed
Autor:
Patrick Magnus, David Goldberg, Alan Wiseman, David Zlotnick, Chad M. Bohn, William J Phillips, David J. Malenka, John E. Jayne, Mirle Kellett, Richard A Boss, Matthew Watkins, Harold Dauerman, John F. Robb, T.P. Ryan
Publikováno v:
Journal of the American College of Cardiology. (10):E1501
The benefit of drug-eluding stents (DES) in reducing target vessel revascularization (TVR) is greatest in patients at high risk of restenosis with bare metal stents (BMS). Lowering the risk of TVR with DES must be weighed against the potential increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9d068746e5c75d4789263c01eaf4c8f